Editorial Board Member - JBBS
Robert R. Redfield
ProfessorDepartment of Immunology and Microbiology
University of Maryland
United States
BIOGRAPHY:
Dr. Robert R. Redfield is currently working as a professor and as IHV Associate Director and Director of the Division of Clinical Care and Research, at University of Maryland, Baltimore. He received many honors and awards in his career. He published many articles in international journals.
RESEARCH INTERESTS:
Dr. Robert R. Redfield research is mainly focused on clinical research and clinical care of chronic human viral infections, especially HIV. His dominant area of research interest is the development of novel biological approaches to the treatment of chronic viral pathogens with a particular focus of targeting host cell pathways for their therapeutic potential. Several novel areas under active translation investigation include: targeting key biochemical pathways of nucleotide biosynthesis to enhance activity of specific antiretroviral medication; targeting cell activation with specific cell cycles as aprimary treatment target; use of G1 cell cycle agents to down regulate expression of key HIV host cell receptors; use of G1 cell cycles to enhance antiviral activity of HIV entry inhibitors; and the use of HIV specific proteins as therapeutic vaccines.
Other Editorial Board Members - JBBS
HamidReza Naderi
Department of Infectious Diseases
Imam Reza University Hospital
Iran
Alcides Troncoso
Department of Microbiology and Infectious Diseases
University of Buenos Aires
Argentina
HENGYI XU
State Key Laboratory of Food Science and Technology
Nanchang University
China
Barbara Anne Curbow
Department of Behavioral and Community Health
School of Public Health
University of Maryland
United States
Li Cai
Department of Biomedical Engineering
Rutgers University
United States
Massimo Ciccozzi
National Institute of Health
Rome
Paban K. Dash
Defence Research & Development Establishment
India
Peter Anderson
Pharmacy Practice
University of Rhode Island
United States
Baolin Zhang
Office of Biotechnology Products
FDA/Center for Drug Evaluation and Research
United States